Valoctocogene Roxaparvovec Rvox + Tenofovir Interaction
Unknowninteraction on record
Description
7.2 Efavirenz One HIV positive patient treated with ROCTAVIAN at a dose of 4 × 10 13 vg/kg ROCTAVIAN while on an antiretroviral therapy regimen consisting of efavirenz, lamivudine, and tenofovir experienced asymptomatic elevations of ALT, AST, and GGT (> 5.0 × ULN) and serum bilirubin (> ULN and up to 1.5 × ULN) at Week 4 [see Use in Specific Populations (8.6) ] .
Source: FDA drug label - valoctocogene roxaparvovec-rvox